179 related articles for article (PubMed ID: 9365233)
1. Simian virus 40, poliovaccines and human tumors: a review of recent developments.
Carbone M; Rizzo P; Pass HI
Oncogene; 1997 Oct; 15(16):1877-88. PubMed ID: 9365233
[TBL] [Abstract][Full Text] [Related]
2. [SV40: a possible co-carcinogen of asbestos in the pathogenesis of mesothelioma?].
Cristaudo A; Foddis R; Bigdeli L; Vivaldi A; Buselli R; Guglielmi G; Guidi M; Ottenga F
Med Lav; 2002; 93(6):499-506. PubMed ID: 12596420
[TBL] [Abstract][Full Text] [Related]
3. Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines.
Hirvonen A; Mattson K; Karjalainen A; Ollikainen T; Tammilehto L; Hovi T; Vainio H; Pass HI; Di Resta I; Carbone M; Linnainmaa K
Mol Carcinog; 1999 Oct; 26(2):93-9. PubMed ID: 10506753
[TBL] [Abstract][Full Text] [Related]
4. New developments about the association of SV40 with human mesothelioma.
Carbone M; Pass HI; Miele L; Bocchetta M
Oncogene; 2003 Aug; 22(33):5173-80. PubMed ID: 12910254
[TBL] [Abstract][Full Text] [Related]
5. Unique strains of SV40 in commercial poliovaccines from 1955 not readily identifiable with current testing for SV40 infection.
Rizzo P; Di Resta I; Powers A; Ratner H; Carbone M
Cancer Res; 1999 Dec; 59(24):6103-8. PubMed ID: 10626798
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for SV40 in human cancer?
Poulin DL; DeCaprio JA
J Clin Oncol; 2006 Sep; 24(26):4356-65. PubMed ID: 16963733
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk associated with simian virus 40 contaminated polio vaccine.
Fisher SG; Weber L; Carbone M
Anticancer Res; 1999; 19(3B):2173-80. PubMed ID: 10472327
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research.
Engels EA
Expert Rev Vaccines; 2005 Apr; 4(2):197-206. PubMed ID: 15889993
[TBL] [Abstract][Full Text] [Related]
9. Simian virus 40, poliovirus vaccines, and human cancer: research progress versus media and public interests.
Butel JS
Bull World Health Organ; 2000; 78(2):195-8. PubMed ID: 10743284
[TBL] [Abstract][Full Text] [Related]
10. Potential exposure to SV40 in polio vaccines used in Sweden during 1957: no impact on cancer incidence rates 1960 to 1993.
Olin P; Giesecke J
Dev Biol Stand; 1998; 94():227-33. PubMed ID: 9776244
[TBL] [Abstract][Full Text] [Related]
11. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas.
Testa JR; Carbone M; Hirvonen A; Khalili K; Krynska B; Linnainmaa K; Pooley FD; Rizzo P; Rusch V; Xiao GH
Cancer Res; 1998 Oct; 58(20):4505-9. PubMed ID: 9788590
[TBL] [Abstract][Full Text] [Related]
12. Simian virus 40 and malignant mesothelioma (Review).
Cerrano PG; Jasani B; Filiberti R; Neri M; Merlo F; De Flora S; Mutti L; Puntoni R
Int J Oncol; 2003 Jan; 22(1):187-94. PubMed ID: 12469203
[TBL] [Abstract][Full Text] [Related]
13. Investigation of simian virus 40 large T antigen in 18 autopsied malignant mesothelioma patients in Japan.
Jin M; Sawa H; Suzuki T; Shimizu K; Makino Y; Tanaka S; Nojima T; Fujioka Y; Asamoto M; Suko N; Fujita M; Nagashima K
J Med Virol; 2004 Dec; 74(4):668-76. PubMed ID: 15484269
[TBL] [Abstract][Full Text] [Related]
14. Examination of poliovirus vaccine preparations for SV40 sequences.
Sangar D; Pipkin PA; Wood DJ; Minor PD
Biologicals; 1999 Mar; 27(1):1-10. PubMed ID: 10441397
[TBL] [Abstract][Full Text] [Related]
15. SV40 expression in human neoplastic and non-neoplastic tissues: perspectives on diagnosis, prognosis and therapy of human malignant mesothelioma.
Procopio A; Marinacci R; Marinetti MR; Strizzi L; Paludi D; Iezzi T; Tassi G; Casalini A; Modesti A
Dev Biol Stand; 1998; 94():361-7. PubMed ID: 9776257
[TBL] [Abstract][Full Text] [Related]
16. The relationship between simian virus 40 and mesothelioma.
Rivera Z; Strianese O; Bertino P; Yang H; Pass H; Carbone M
Curr Opin Pulm Med; 2008 Jul; 14(4):316-21. PubMed ID: 18520265
[TBL] [Abstract][Full Text] [Related]
17. [SV40 as a possible cofactor in the etiopathogenesis of mesothelioma and other human tumors].
Barbanti-Brodano G; Trabanelli C; Lazzarin L; Martini F; Merlin M; Calza N; Corallini A; Tognon M
G Ital Med Lav Ergon; 1998; 20(4):218-24. PubMed ID: 9987613
[TBL] [Abstract][Full Text] [Related]
18. Association of SV40 with human tumours.
Jasani B; Cristaudo A; Emri SA; Gazdar AF; Gibbs A; Krynska B; Miller C; Mutti L; Radu C; Tognon M; Procopio A
Semin Cancer Biol; 2001 Feb; 11(1):49-61. PubMed ID: 11243899
[TBL] [Abstract][Full Text] [Related]
19. Association of SV40 with human tumors.
Klein G; Powers A; Croce C
Oncogene; 2002 Feb; 21(8):1141-9. PubMed ID: 11850833
[TBL] [Abstract][Full Text] [Related]
20. SV40, genetic polymorphism and mesothelioma. pathological and epidemiological evidence.
Magnani C
Med Lav; 2005; 96(4):347-53. PubMed ID: 16457431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
